188 related articles for article (PubMed ID: 32679794)
1. The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer.
Gerashchenko TS; Zolotaryova SY; Kiselev AM; Tashireva LA; Novikov NM; Krakhmal NV; Cherdyntseva NV; Zavyalova MV; Perelmuter VM; Denisov EV
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679794
[TBL] [Abstract][Full Text] [Related]
2. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.
Xu J; Zhang W
Cancer Cell Int; 2021 Oct; 21(1):521. PubMed ID: 34627255
[TBL] [Abstract][Full Text] [Related]
3. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.
Corson TW; Gallie BL
Int J Cancer; 2006 Sep; 119(5):1088-94. PubMed ID: 16570270
[TBL] [Abstract][Full Text] [Related]
4. High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients.
Zhang R; Zhang S; Xing R; Zhang Q
Thorac Cancer; 2019 Oct; 10(10):1953-1961. PubMed ID: 31452341
[TBL] [Abstract][Full Text] [Related]
5. Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Gaowa S; Futamura M; Tsuneki M; Kamino H; Tajima JY; Mori R; Arakawa H; Yoshida K
Cancer Sci; 2018 Dec; 109(12):3910-3920. PubMed ID: 30290054
[TBL] [Abstract][Full Text] [Related]
6. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
[TBL] [Abstract][Full Text] [Related]
7.
Futamura M; Tokumaru Y; Takabe K; Arakawa H; Asano Y; Mori R; Mase J; Nakakami A; Yoshida K
Am J Cancer Res; 2021; 11(12):6060-6073. PubMed ID: 35018242
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44
Denisov EV; Skryabin NA; Gerashchenko TS; Tashireva LA; Wilhelm J; Buldakov MA; Sleptcov AA; Lebedev IN; Vtorushin SV; Zavyalova MV; Cherdyntseva NV; Perelmuter VM
Oncotarget; 2017 Sep; 8(37):61163-61180. PubMed ID: 28977854
[TBL] [Abstract][Full Text] [Related]
9. Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer.
Xiao G; Cheng F; Yuan J; Lu W; Wang P; Fan H
Oncol Res; 2022; 30(1):35-51. PubMed ID: 37304008
[TBL] [Abstract][Full Text] [Related]
10. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF
Hamada K; Kurashige T; Shimamura M; Arakawa H; Nakamura Y; Nagayama Y
Front Endocrinol (Lausanne); 2022; 13():932754. PubMed ID: 36187114
[TBL] [Abstract][Full Text] [Related]
11. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
12. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
Singel SM; Cornelius C; Zaganjor E; Batten K; Sarode VR; Buckley DL; Peng Y; John GB; Li HC; Sadeghi N; Wright WE; Lum L; Corson TW; Shay JW
Neoplasia; 2014 Mar; 16(3):247-56, 256.e2. PubMed ID: 24784001
[TBL] [Abstract][Full Text] [Related]
13. The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma.
Hung PF; Hong TM; Hsu YC; Chen HY; Chang YL; Wu CT; Chang GC; Jou YS; Pan SH; Yang PC
PLoS One; 2013; 8(4):e61664. PubMed ID: 23626713
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity.
Gerashchenko TS; Zavyalova MV; Denisov EV; Krakhmal NV; Pautova DN; Litviakov NV; Vtorushin SV; Cherdyntseva NV; Perelmuter VM
Acta Naturae; 2017; 9(1):56-67. PubMed ID: 28461975
[TBL] [Abstract][Full Text] [Related]
15. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.
Jiang W; Wang J; Yang X; Shan J; Zhang Y; Shi X; Wang Y; Chenyan A; Chang J; Wang Y; Yu Y; Li C; Li X
Oncogene; 2023 Apr; 42(17):1392-1404. PubMed ID: 36922675
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA EZR-AS1 promotes tumor growth and metastasis by modulating Wnt/β-catenin pathway in breast cancer.
Bai Y; Zhou X; Huang L; Wan Y; Li X; Wang Y
Exp Ther Med; 2018 Sep; 16(3):2235-2242. PubMed ID: 30186463
[TBL] [Abstract][Full Text] [Related]
17.
Cheng C; Wu X; Shen Y; Li Q
Cancer Manag Res; 2020; 12():13241-13257. PubMed ID: 33380832
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma.
Klimaszewska-Wiśniewska A; Neska-Długosz I; Buchholz K; Durślewicz J; Grzanka D; Kasperska A; Antosik P; Zabrzyński J; Grzanka A; Gagat M
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208606
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis.
Tashireva LA; Denisov EV; Gerashchenko TS; Pautova DN; Buldakov MA; Zavyalova MV; Kzhyshkowska J; Cherdyntseva NV; Perelmuter VM
Immunobiology; 2017 Apr; 222(4):631-640. PubMed ID: 27916281
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53.
Nakamura Y; Arakawa H
Cancer Sci; 2017 May; 108(5):809-817. PubMed ID: 28222492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
